You are here

Home

Knowledge Science

Primary tabs

Wed, 2011-06-15 08:18 — mdmcdonald
The Knowledge Science working group is focused on exploring the advancement of knowledge science.

The mission of the Knowledge Science working group is to explore the advancement of knowledge science.

Add Content to this group

Click to add a new Group Post Simple to this group
Click to add a new Group Post Simple w Images to this group
Click to add a new Group Post to this group
Click to add a new PRIVATE Group Post to this group
Click to add a new TASK to this group

Members

Joyce Fedeczko Kathy Gilbeaux Maeryn Obley mdmcdonald mike kraft Siftar
tkm tom.mcginn
Subscribe to group

Email address for group

knowledge-science@m.resiliencesystem.org

Five tactics used to spread vaccine misinformation in the wellness community, and why they work

Fri, 2021-10-22 17:50 — mike kraft
Five tactics used to spread vaccine misinformation in the wellness community, and why they work The content shared in some online wellness spaces has powerful emotional and psychological foundations that can cause even science-minded people to question the public health consensus on the ability of vaccines to help curb the spread of the coronavirus. Washington Post

...

Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Disease
Health
Pandemics
Politics
Social behavior
Vaccinations
Communication
Problem, Solution, SitRep, or ?: 
Analysis
Situation Report

Children with mild COVID-19 may not develop antibodies; oral vaccine shows promise in monkey study

Wed, 2021-10-20 17:41 — mike kraft
Children with mild COVID-19 may not develop antibodies; oral vaccine booster shows promise in monkey study The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that have yet to be certified by peer review. Nancy Lapid Reuters
Country / Region Tags: 
Australia
Global
United States
General Topic Tags: 
COVID-19
Contagion
Data
Disease
Health
Medical Testing
Pandemics
Research
Problem, Solution, SitRep, or ?: 
Analysis
Situation Report

COVID's Mysterious 2-Month Cycle --Trying to Understand it

Mon, 2021-10-04 11:20 — mike kraft
Trying to Make Sense of COVID's Mysterious 2-Month Cycle COVID-19 is once again in retreat. The reasons remain somewhat unclear, and there is no guarantee that the decline in caseloads will continue. But the turnaround is now large enough — and been going on long enough — to deserve attention. Sign up for The Morning newsletter from the New York Times The number of new daily cases in the United States has fallen 35% since Sept. 1. Worldwide, cases have also dropped more than 30% since late August.
Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Data
Public Health
Social behavior
Contagion
Disease
Health
Pandemics
Science
Problem, Solution, SitRep, or ?: 
Analysis

Studies indicate that the Coronavirus May Be Getting Better at Airborne Transmission

Fri, 2021-10-01 19:58 — mike kraft

Newer variants of the coronavirus like Alpha and Delta are highly contagious, infecting far more people than the original virus. Two new studies offer a possible explanation: The virus is evolving to spread more efficiently through air.

The realization that the coronavirus is airborne indoors transformed efforts to contain the pandemic last year, igniting fiery debates about masks, social distancing and ventilation in public spaces.

Country / Region Tags: 
Global
United States
General Topic Tags: 
Adaptation
COVID-19
Mutations
Contagion
Disease
Health
Pandemics
Research
Problem, Solution, SitRep, or ?: 
Analysis

COVID-19 pill developers aim to top Merck, Pfizer efforts

Tue, 2021-09-28 17:52 — mike kraft

Enanta Pharmaceuticals, Pardes Biosciences, Japan’s Shionogi & Co Ltd and Novartis AG said they have designed antivirals that specifically target the coronavirus while aiming to avoid potential shortcomings such as the need for multiple pills per day or known safety issues.

Infectious disease experts stressed that preventing COVID-19 through wide use of vaccines remains the best way to control the pandemic. But they said the disease is here to stay and more convenient treatments are needed here.

“We need to have oral alternatives for suppression of this virus. We have people who aren’t vaccinated getting sick, people whose vaccine protection is waning, and people who can’t get vaccinated,” said Dr. Robert Schooley, an infectious diseases professor at UC San Diego School of Medicine.

Pfizer and Merck, as well as partners Atea Pharmaceuticals and Roche AG have all said they could seek emergency approval for their COVID-19 antiviral pills this year.

Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Medical Testing
Public Health
Health
Pandemics
Research
Problem, Solution, SitRep, or ?: 
Situation Report

Are at-home covid tests accurate? What the results can and can’t tell you.

Tue, 2021-09-21 19:26 — mike kraft
Are at-home covid tests accurate? What the results can and can’t tell you. While at-home coronavirus tests can be a useful diagnostic tool, the tests aren’t 100 percent accurate and a negative result shouldn’t be thought of as a “free pass.” Allyson Chiu Washington Post
Country / Region Tags: 
United States
General Topic Tags: 
COVID-19
Medical Testing
Contagion
Disease
Health
Pandemics
Science
Problem, Solution, SitRep, or ?: 
Analysis

NIH awards $470 M for a large study on the long term effects of COVID-19 infections.

Wed, 2021-09-15 16:26 — mike kraft
NIH awards $470M to NYU Langone Health to build long COVID-19 study The National Institutes of Health (NIH) awarded almost $470 million to New York University (NYU) Langone Health to build a national study population of tens of thousands of people to research the Justine Coleman TheHill
Country / Region Tags: 
United States
General Topic Tags: 
COVID-19
Data
Medical Testing
Public Health
Vaccinations
Contagion
Disease
Health
Pandemics
Research
Problem, Solution, SitRep, or ?: 
Situation Report

Breakthough Infections Are Less Likely to Lead to Long COVID-- British Study Suggests

Thu, 2021-09-02 10:08 — mike kraft
Study: Vaccination lowers long Covid risk, even when people are infected The research is among the earliest evidence that immunization reduces the risk of long Covid even when a breakthrough infection occurs. Andrew Joseph STAT

People who are fully vaccinated against Covid-19 appear to have a much lower likelihood of developing long Covid than unvaccinated people even when they contract the coronavirus, a study published Wednesday indicated.

Country / Region Tags: 
Global
UK - London
United Kingdom
General Topic Tags: 
Medical Testing
Vaccinations
Contagion
Disease
Health
Pandemics
Research
Problem, Solution, SitRep, or ?: 
Analysis

Virus Symptoms Can Last a Year-- New Study

Fri, 2021-08-27 10:32 — mike kraft

A new study found half of Covid patients had lingering symptoms one year later.

One year after becoming ill with the coronavirus, nearly half of patients in a large new study were still experiencing at least one lingering health symptom, adding to evidence that recovery from Covid-19 can be arduous and that the multifaceted condition known as “long Covid” can last for months.

The study, published Thursday in the journal The Lancet, is believed to be the largest to date in which patients were evaluated one year after being hospitalized for Covid. It involved 1,276 patients admitted to Jin Yin-tan Hospital in Wuhan, China, who were discharged between Jan. 7 and May 29, 2020.

Country / Region Tags: 
China
Global
United States
General Topic Tags: 
COVID-19
Data
Medical Testing
Public Health
Contagion
Disease
Health
Pandemics
Research
Problem, Solution, SitRep, or ?: 
Analysis

Overview: Research on monoclonal antibodies to protect against COVID-19 variants

Wed, 2021-08-25 12:43 — mike kraft
COVID SCIENCE-Researchers seek powerful antibody against many variants; breakthrough cases may be less infectious Two separate research teams last week reported on laboratory tests of monoclonal antibodies that appear to protect against a broad range of COVID-19 virus variants. One study, published on Wednesday in The New England Journal of Medicine bit.ly/3kgzEZU, identified "high-level, broad-spectrum" antibodies in blood samples from survivors of the original SARS outbreak in 2003 who recently received the Pfizer/BioNTech vaccine against SARS-CoV-2, the virus that causes COVID-19.
Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Medical Testing
Mutations
Public Health
Vaccinations
Contagion
Disease
Health
Pandemics
Research
Problem, Solution, SitRep, or ?: 
Analysis

Pages

howdy folks
Page loaded in 0.710 seconds.